MDLN

$42.18+0.43 (+1.03%)

Market OpenAs of Mar 17, 7:10 PM UTC

Medline Inc.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$42.18
Potential Downside
34.5%
Whystock Fair Value$27.61
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Instruments & Supplies

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and ...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$34.24B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
29.50
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
6.53%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
2.21

Recent News

Insider Monkey
Mar 14, 2026

Medline Inc (MDLN) Plans to Expand Distribution Centers

Medline Inc. (NASDAQ:MDLN) is one of the Best Young Stocks To Buy and Hold For 20 Year. On March 11, Medline Inc. (NASDAQ:MDLN) announced that it plans to expand its network of 45 distribution centers with the addition of a new 1.2 million sq. ft. distribution center in Midlothian, Texas. ​Management noted that this is […]

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Mar 12, 2026

Assessing Medline (MDLN) Valuation After A Recent 10% Share Price Pullback

Context around Medline’s recent share performance With no single headline event driving headlines, Medline (MDLN) has still been on investor radars after a month return of about 10% decline, even as its year to date return remains positive. See our latest analysis for Medline. Medline’s recent 10.5% 30 day share price return decline contrasts with a 4.4% year to date share price return, indicating that near term momentum has cooled even as the longer trend remains positive around the current...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
24/7 Wall St.
Mar 11, 2026

Here Are Wednesday’s Top Wall Street Analyst Research Calls: CrowdStrike, Harley-Davidson, Intuitive Surgical, Medline, Nike, Oracle, Planet Fitness, Vici Properties, and More

Pre-Market Stock Futures: Futures are trading lower as we hit the mid-point of the trading week, and while we didn’t see the snapback rally that was the star of the show Monday, at least all four major indices held their own as the conflict in Iran grinds on. The Nasdaq was able to eke out ... Here Are Wednesday’s Top Wall Street Analyst Research Calls: CrowdStrike, Harley-Davidson, Intuitive Surgical, Medline, Nike, Oracle, Planet Fitness, Vici Properties, and More

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Insider Monkey
Mar 10, 2026

Medline (MDLN) Q4 Net Sales Rise 14.8% to $7.8B Following Completion of IPO

Medline Inc. (NASDAQ:MDLN) is one of the best NASDAQ stocks to buy according to hedge funds. On February 25, Medline reported its Q4 and full-year 2025 financial results, marking a significant year that included the completion of its initial public offering. For Q4, the company achieved net sales of $7.8 billion, representing a 14.8% increase […]

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
MT Newswires
Mar 5, 2026

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Amid Continued Middle East Conflict

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.2% and the actively tr

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.